Balance Sheet Data

Nektar Therapeutics (NKTR)

$2.91

0.00 (0.00%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 296.131,335.351,324.861,061.90733.95845.921,263.531,887.292,818.994,210.65
Total Cash (%)
Account Receivables 5.0143.2136.8038.8922.4925.8338.5957.6486.09128.59
Account Receivables (%)
Inventories 10.7311.3812.6715.2915.8012.4818.6427.8441.5962.12
Inventories (%)
Accounts Payable 4.785.8519.2322.149.7513.0519.4929.1243.4964.96
Accounts Payable (%)
Capital Expenditure -9.68-14.24-26.29-7.26-14.99-14.22-21.25-31.74-47.40-70.80
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.